Form D · Biotechnology

TORQUE THERAPEUTICS, INC.

Cambridge, MA · CIK 0001651069

Offering snapshot reported Jul 16, 2019 · SEC filing

Reported sold
$38.3M
Offering amount: $38.3M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 1, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 16, 2019Initial$38,275,890No comparison8SEC filing
Apr 19, 2018Amendment$45,998,335$25,000,002vs Aug 29, 20177SEC filing
Aug 29, 2017Amendment$20,998,333$15,998,333vs Aug 28, 20155SEC filing
Aug 28, 2015Initial$5,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-344458

Source: Form D, filed Jul 16, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Doug Cole Director
Douglas G. Cole Director
John G. Cox Director, Executive
John M. Dineen Director
Bart Henderson Director, Executive
John A. Hohneker Director
Darrell Irvine Director
Douglas A. Lauffenburger Director
Doug Lauffenburger Director
Keith Marshall Executive
Ulrik B. Nielsen Director, Executive, Promoter
Vikas Sinha Director
Sok Cheng Soh Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
One Kendall Square Building 1400 W, 5 Th Floor
Cambridge, MA, 02139